Diagnosis and classification of ulcerative colitis

被引:255
作者
Conrad, Karsten [1 ]
Roggenbuck, Dirk [2 ,3 ]
Laass, Martin W. [4 ]
机构
[1] Tech Univ Dresden, Inst Immunol, Fac Med, D-01307 Dresden, Germany
[2] Brandenburg Tech Univ Cottbus Senftenberg, Fac Sci, Senftenberg, Germany
[3] GA Gener Assays GmbH, Dahlewitz, Germany
[4] Tech Univ Dresden, Dept Paediat, Fac Med, D-01307 Dresden, Germany
关键词
Inflammatory bowel diseases; Ulcerative colitis; Crohn's disease; Diagnostic criteria; INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; EPIDEMIOLOGY; PATHOGENESIS; MANAGEMENT; ACID;
D O I
10.1016/j.autrev.2014.01.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease (IBD) characterised by superficial mucosal ulceration, rectal bleeding, diarrhoea, and abdominal pain. In contrast to Crohn's disease (CrD), UC is restricted to the colon and the inflammation is limited to the mucosal layer. Classic UC affects the colon in a retrograde and continuous fashion starting from the rectum and extending proximally. Dependent on the anatomic extent of involvement, UC can be classified as proctitis, left-sided colitis, or pancolitis. Inflammatory arthropathies and primary sclerosing cholangitis (PSC) are the most common and clinically most important extraintestinal manifestations of UC. The aetiopathogenesis of UC is incompletely understood, but immune-mediated mechanisms are responsible for dysregulated immune responses against intraluminal antigens in genetically predisposed individuals. The diagnosis is based on the history, as well as clinical, radiological, endoscopic and histological features. Autoantibodies, mainly antineutrophil cytoplasmic antibodies (ANCA) and anti-goblet cell antibodies (GAB) may be helpful in the early diagnosis of UC and in differentiating it from CrD. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:463 / 466
页数:4
相关论文
共 28 条
  • [1] [Anonymous], 2007, J PEDIATR GASTR NUTR, V44, P653
  • [2] Serologic markers in inflammatory bowel disease
    Bossuyt, X
    [J]. CLINICAL CHEMISTRY, 2006, 52 (02) : 171 - 181
  • [3] Update on the Heritability of Inflammatory Bowel Disease: The Importance of Twin Studies
    Brant, Steven R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 1 - 5
  • [4] EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE
    CALKINS, BM
    MENDELOFF, AI
    [J]. EPIDEMIOLOGIC REVIEWS, 1986, 8 : 60 - 91
  • [5] Conrad K, 2002, EUR J GASTROEN HEPAT, V14, P1
  • [6] Conrad K, 2007, AUTOANTIBODIES, 2ND EDITION, P417, DOI 10.1016/B978-044452763-9/50056-1
  • [7] Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
    Devkota, Suzanne
    Wang, Yunwei
    Musch, Mark W.
    Leone, Vanessa
    Fehlner-Peach, Hannah
    Nadimpalli, Anuradha
    Antonopoulos, Dionysios A.
    Jabri, Bana
    Chang, Eugene B.
    [J]. NATURE, 2012, 487 (7405) : 104 - +
  • [8] Ekbom A, 2003, INFLAMM BOWEL DIS, P5
  • [9] Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1
  • [10] Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
    Hanauer, SB
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 : S3 - S9